10 Stocks to Buy According to Neil Shahrestani's Ikarian Capital
In this article, we will take a look at the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.
Ikarian Capital was established in Q1 2015 by Neil Shahrestani and Chart Westcott. Headquartered in Dallas, Texas, the firm specializes in long/short equity hedge fund management with a strong focus on the therapeutics and biotechnology sectors
Dr. Neil Tristan Shahrestani is the founder and Chief Executive Officer of Ikarian Capital LLC, established in 2015. Before founding Ikarian Capital, he served as an Analyst at S.A.C. Capital Advisors LP in 2013 and Goldman Sachs & Co. LLC from 2011 to 2013. He also held the position of Senior Analyst at Pura Vida Investments LLC. Dr. Shahrestani earned his undergraduate degree from Columbia University in New York City and obtained a doctorate from Ross University School of Medicine in 2008.
Ikarian Capital, as of their Form ADV dated March 2024, manages discretionary assets totaling $565,157,554 for 5 clients. Their Q1 2024 13F filing reported managing $912,049,481 in 13F securities, with a top 10 holdings concentration of 35.78%. Krystal Biotech Inc. represents their largest holding, with 375,000 shares held.
